Transfusion therapy and acute lung injury

Area of Science:

• Hematology
• Critical Care Medicine
• Immunology

Background:

• Transfusion-related acute lung injury (TRALI) is the most fatal transfusion complication.
• Existing TRALI definitions are debated, but recent data link transfusions to acute lung injury in critically ill and trauma patients.
• Plasma and platelet transfusions are frequently implicated in TRALI.

Purpose of the Study:

• To review the current understanding of TRALI pathogenesis, diagnosis, and management.
• To highlight evidence supporting the link between blood transfusions and acute lung injury.
• To discuss preventive strategies for TRALI.

Main Methods:

• Literature review of recent evidence on TRALI.
• Analysis of the 'two hit' model for TRALI pathogenesis.
• Evaluation of current and proposed treatment and prevention strategies.

Main Results:

• The 'two hit' model offers a framework for understanding TRALI's immune and nonimmune pathways.
• Supportive care is the primary treatment for TRALI.
• Using predominantly male plasma and apheresis platelets are effective measures to decrease TRALI incidence.

Conclusions:

• Further research into blood components and patient risk factors is crucial for developing novel TRALI treatments.
• Implementing strategies like male plasma use can mitigate the risk of this life-threatening syndrome.
• Understanding TRALI's complex pathogenesis is key to improving patient outcomes.